Related Experiment Video
Updated: Dec 17, 2025

05:51
Intracerebroventricular and Intravascular Injection of Viral Particles and Fluorescent Microbeads into the Neonatal Brain
Published on: July 24, 2016
20.2K
Changes in laboratory findings in Parechovirus-A infection in nine neonates and infants
Keiko Nimura1, Yuta Maruyama2, Yuta Aizawa3
1Department of Pediatrics, Nagano Red Cross Hospital, Nagano, Japan.
Abstract
No abstract available in PubMed .
Related Concept Videos
Acute Pyelonephritis II: Diagnostic Studies and Management
199
Introduction:For diagnosing acute pyelonephritis, a comprehensive patient history is collected to identify symptoms such as dysuria, frequent or urgent urination, flank pain, or costovertebral angle (CVA) tenderness that may suggest a kidney infection.Physical ExaminationDuring the physical examination, CVA tenderness is assessed. This involves gentle percussion over the costovertebral angle, where tenderness often indicates a kidney infection.Diagnostic TestsUrinalysis: Used to identify white...
199
Pneumonia III: Complications and Assessment
688
Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
688
Pharmacokinetics in Pediatric Patients: Drug Excretion
141
In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
141
Pharmacokinetics in Pediatric Patients: Drug Metabolism
121
In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
121

